Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
http://img.marketwire.com/rss/mwPBES.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  announces  apr  cannabis  company  development  marketwired apr  marketwired april  marketwired  medical  new  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies



Marketwired - Equipment and Supplies



Last Build Date: Mon, 24 Apr 2017 18:19:28 EDT

Copyright: Copyright: (C) Marketwired
 



biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director

Mon, 24 Apr 2017 17:07:00 EDT

VANCOUVER, BC--(Marketwired - April 24, 2017) -




Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call

Mon, 24 Apr 2017 16:05:00 EDT

MENLO PARK, CA--(Marketwired - Apr 24, 2017) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 1, 2017. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).




OntarioMD appoints new skills-based Board of Directors to guide strategic direction

Mon, 24 Apr 2017 15:20:00 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - OntarioMD is pleased to announce that it has concluded its search for a new Board of Directors to guide the company to achieve its vision and mission to expand the adoption and enhanced use of digital health solutions for community-based physicians and to further support its new strategic direction.




Science Exchange Invited to Speak at the 20th Annual Milken Institute Global Conference 2017

Mon, 24 Apr 2017 11:00:00 EDT

Elizabeth Iorns, Ph.D., Founder and CEO of Science Exchange, joins panel to discuss how today's young entrepreneurs are reshaping the biopharma business model




NSAV Announces 10% Stock Dividend and June 1 Record Date

Mon, 24 Apr 2017 09:00:00 EDT

CRESCO, PA--(Marketwired - Apr 24, 2017) - Net Savings Link, Inc. (OTC: NSAV) announced today that the Company has declared a 10% stock dividend to stockholders of record on June 1, 2017. The stock dividend will be paid on or around June 29, 2017. 




Bellatora, Inc. Partners with Award Winning Agronomist, Enters Multi-Billion Dollar Medical Marijuana Vaping Sector

Mon, 24 Apr 2017 09:00:00 EDT

ANAHEIM, CA--(Marketwired - Apr 24, 2017) - Bellatora Inc. (OTC: ECGR) is a U.S.-based manufacturer, marketer, and distributor of innovative vaporizer products and eLiquids for alternative tobacco and marijuana consumption. 




eWellness Executes PHZIO Beta User Agreement with Jackson Clinics

Mon, 24 Apr 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Apr 24, 2017) - eWellness Healthcare Corporation (OTCQB: EWLL), a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it has executed a 90-day PHZIO beta user agreement with Jackson Clinics, LP, which has 15 clinics located in Northern Virginia, https://thejacksonclinics.com.




TrendMiner Software is being rolled out by Total's Refining & Chemicals Segment

Mon, 24 Apr 2017 08:30:00 EDT

TrendMiner predictive analytics software selected by Total to facilitate self-service analytics and process performance optimization of its Refining & Chemicals segment




Lion Biotechnologies to Host Conference Call to Discuss First Quarter 2017 Financial and Operating Results on Monday, May 1, 2017

Mon, 24 Apr 2017 08:00:00 EDT

SAN CARLOS, CA--(Marketwired - April 24, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report its first quarter 2017 financial and operating results after the close of the U.S. financial markets on Monday, May 1, 2017. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 5:00 p.m. ET.




SpeeDx and Thermo Fisher Scientific Announce Strategic Partnership for FDA Clearance of Molecular Diagnostic

Mon, 24 Apr 2017 08:00:00 EDT

ResistancePlus(TM) MG Test would bring disease and antibiotic resistance testing to U.S. market for sexually transmitted infection and potential "superbug"




ORYZON Announces New Grant from Alzheimer's Drug Discovery Foundation (ADDF) to develop a companion marker for its ORY-2001 epigenetic drug

Mon, 24 Apr 2017 08:00:00 EDT

ADDF to increase its stake in the company to reach 0.77 % of the common stock




Amfil Technologies, Inc. Provides Update on Snakes & Lagers Inc./Snakes & Lattes Inc. Subsidiary Including Largest Purchase Order to Date, New Partnerships & 3rd Location Construction & Opening

Mon, 24 Apr 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Apr 24, 2017) - Amfil Technologies, Inc. (OTC PINK: AMFE) is pleased to provide shareholders and the investment community with an update on our Snakes & Lattes Inc./Snakes & Lagers Inc. subsidiary.




Nephros Announces Partnership with WorldWater & Solar Technologies

Mon, 24 Apr 2017 07:31:02 EDT

RIVER EDGE, NJ--(Marketwired - Apr 24, 2017) -  Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to drive motors and pumps in large-scale irrigation and municipal water delivery systems, jointly announced today that they have signed a partnership agreement to incorporate Nephros ultrafilters into their solar powered drinking water systems.




Upcoming Webinar to Optimise Your Medical Publications and Avoid "Predatory Journals"

Mon, 24 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 24, 2017) - On Tuesday, May 9, 2017, join a panel of industry experts to learn tips and tools to enhance your medical publication efforts and avoid so-called "predatory journals". Jeffrey Beall, Scholarly Communications Librarian and Associate Professor at the University of Colorado Denver, and ICON's PubsHub team will discuss the growth of open access publishing and what precautions you can take to avoid falling into costly and career damaging traps. Learn best practices and tools to:




Turning Biorepositories into Translational Science Treasure Troves, New Webinar Hosted by Xtalks

Mon, 24 Apr 2017 07:00:00 EDT

The Value of Uniquely Complete Data Sets, Put All Your Specimens -- and All of Their Data -- At Your Fingertips System




Akers Biosciences Updates on Akers Wellness(TM) Tests

Mon, 24 Apr 2017 07:00:00 EDT

Akers Wellness iOS digital application approved by the Apple App Store




Amedica Announces Regulatory Clearance to Market and Sell Valeo(R) Silicon Nitride Spinal Implants in Australia

Mon, 24 Apr 2017 07:00:00 EDT

Australian Marketing Clearance Provides Opportunities for Global Expansion




Cannabis Science Continues Expansions as it Negotiates to Acquire Two Medical Marijuana Dispensaries in Los Angeles, California; The Company Expects to Sign Closing Documents Shortly

Fri, 21 Apr 2017 12:12:22 EDT

CBIS Negotiates for Two Los Angeles, California Medical Marijuana Dispensaries Right Before the Global Health Catalyst Summit at Harvard




Rennova Health's Big South Fork Medical Center Moves Closer to Opening

Fri, 21 Apr 2017 08:30:00 EDT

WEST PALM BEACH, FL --(Marketwired - April 21, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that the Centers for Medicare and Medicaid Services (CMS) has concluded its review of the application submitted by its subsidiary Big South Fork Medical Center (Legal Name: Scott Community Hospital, Inc.) requesting enrollment in the Medicare program as a Hospital. CMS has confirmed that it has issued a recommendation for approval to the Tennessee State Agency and the CMS Regional Office (RO).




Amfil Technologies Inc. Provides Update on GROzone Subsidiary Developments

Fri, 21 Apr 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - Apr 21, 2017) - Amfil Technologies Inc. (OTC PINK: AMFE) is pleased to announce that we have jointly signed non-disclosure / confidentiality agreements with a large hydroponic systems manufacturer and have begun the due diligence process to engage in a venture to integrate and distribute the GROzone EcoPr03 Antimicrobial System as a customized add-on to their hydroponic systems. There will be dual announcements naming the partner shortly as they have requested additional time to prepare and so additional agreements can be finalized. This manufacturer will be receiving their first EcoPro3 unit in the coming weeks.




Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

Fri, 21 Apr 2017 06:00:00 EDT

NOVATO, CA--(Marketwired - Apr 21, 2017) - Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce that the European Patent Office has allowed a key patent for TAM-01, a novel mTOR modulator, targeting unmet need in systemic lupus erythematosus (SLE). The patent, owned by the Buck Institute for Research on Aging and licensed exclusively to Mount Tam Biotechnologies, provides composition of matter protection for Mount Tam's lead compound in Europe, further strengthening Mount Tam's strong intellectual property position in the United States and Japan.




Aevi Genomic Medicine Presents Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

Thu, 20 Apr 2017 16:30:00 EDT

PHILADELPHIA, PA--(Marketwired - Apr 20, 2017) -




Avantor Acquires Puritan Products

Thu, 20 Apr 2017 15:30:00 EDT

Acquisition bolsters Avantor's portfolio of high-purity cGMP materials and solutions for Biopharma, Research and Electronic Materials customers




Former Megaupload Programming Team Joins mCig, Inc. in the Cannabis Tech Space

Thu, 20 Apr 2017 12:17:53 EDT

HENDERSON, NV--(Marketwired - Apr 20, 2017) - mCig, Inc., (OTCQB: MCIG) a leading distributor of innovative products, technologies and services for the global medical marijuana industry, is pleased to announce the achievement of acquiring part of the former Megaupload development team. The team is led by Chief Technologist, Andrus Nomm, recognized as the senior operative and programming lead in the popular online file sharing, streaming and ad serving websites of MEGAupload, MEGAclick and MEGAvideo. The sites served approximately 50 million users per day over 6500+ servers, monetizing over a quarter billion USD in advertising and subscription revenue. 




Parsec Unveils Key Enhancements in TrakSYS Version 10.1

Thu, 20 Apr 2017 12:10:10 EDT

New Features Fulfill on Mission to Simplify Manufacturing Management Software with Additional Out-of-Box Functionality and Code-Free Configuration




BDS Introduces the New L-Series LED Patient Light

Thu, 20 Apr 2017 12:01:29 EDT

NEWBERG, OR--(Marketwired - Apr 20, 2017) - Beaverstate Dental Systems (BDS) announces the release of their new L-series LED patient light. "We have designed an operatory light that provides all the advantages of an LED, while remaining in the comparable price range of a halogen," states BDS President Rick Whitman. "We excel at offering more bang for the buck, each and every time. It doesn't have to cost you more to get a long-lived, reliable product. Our L-Series is low wattage, with a 5,000-5,500 K color temperature. With multiple mounting configurations and 3-Axis head rotation, our LED lends itself to increased flexibility."




Ogilvy CommonHealth Worldwide strengthens its creative offering with executive-level new hire and promotions

Thu, 20 Apr 2017 11:26:36 EDT

PARSIPPANY, NJ--(Marketwired - Apr 20, 2017) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com) and a WPP Health & Wellness company (NASDAQ: WPPGY) (www.wpp.com), today announced one new hire and three promotions at the executive vice president, creative director level in the network's New Jersey headquarters.




Cannabis Science Issues First Quarter Update and Celebrates 4/20 With Unprecedented Revenue Growth Projections and Sustainable Equity Value Looking Forward to More Quarterly Growth and Progress Reports

Thu, 20 Apr 2017 11:18:02 EDT

IRVINE, CA--(Marketwired - Apr 20, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, recently announced a pending offering memorandum for expansion capital, another large drug development deal, and an expedited seeding schedule, all of which are expected to create sustainable equity value and unprecedented revenue growth for the company.




Propanc CEO James Nathanielsz's FDA Policy Proposals Published in Pharma Trade Media

Thu, 20 Apr 2017 10:07:05 EDT

Company completes 1-for-250 reverse split and name change to Propanc Biopharma Inc.




Aphria Raises $100 Million to Fund Continued Expansion of Production Capacity and Other Strategic Opportunities

Thu, 20 Apr 2017 09:15:21 EDT

LEAMINGTON, ONTARIO--(Marketwired - April 20, 2017) -




MyDx Releases Earnings Call Investor Presentation

Thu, 20 Apr 2017 09:00:00 EDT

Invites Industry and Media to Learn More About MyDx Breakthrough Technology Setting the Foundation for the Future of Cannabis




BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis

Thu, 20 Apr 2017 08:30:00 EDT

FREDERICK, MD--(Marketwired - Apr 20, 2017) - BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy. The president of BioElectronics, Andrew Whelan was interviewed by UpTick Radio about the ActiPatch technology. The full transcript is available at (https://upticknewswire.com/wp-content/uploads/2017/04/Uptick-Network-BIEL-Interview-04-13-17.mp3)




Atossa Genetics Receives Positive Interim Review From Independent Safety Committee in Phase 1 Endoxifen Dose Escalation Study

Thu, 20 Apr 2017 08:15:00 EDT

SEATTLE, WA--(Marketwired - Apr 20, 2017) -  Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company, today announced that it has received a positive interim review on its Phase 1 study of endoxifen, which is an active metabolite of the FDA approved drug tamoxifen, which is indicated for breast cancer and breast cancer prevention in high risk patients. The Independent Safety Committee reviewed the blinded data generated from the first cohort of the study (8 subjects) and concluded that the study may advance to the next dosing level.




Vitality Biopharma Releases Clinical Report of Cannabinoid Therapy for Pediatric IBD

Thu, 20 Apr 2017 08:00:00 EDT

Cannabinoid therapy was able to successfully induce and maintain long-term remission in case study of drug-resistant pediatric inflammatory bowel disease




Aldeyra Therapeutics, Inc. Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-102 in Sjögren-Larsson Syndrome

Thu, 20 Apr 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Apr 20, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules, today announced that the United States Food and Drug Administration (FDA) has granted Aldeyra's novel compound ADX-102 orphan drug designation for the treatment of congenital ichthyosis, a severe skin disease characteristic of Sjögren-Larsson Syndrome (SLS). There are no FDA-approved therapies specifically indicated for the treatment of SLS, and ADX-102 is believed to be the only potential SLS therapy in clinical development.




The New Gold Standards of IRT Delivery for Clinical Trials, New Webinar Hosted by Xtalks

Thu, 20 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 20, 2017) - In a live presentation, Grant Dietrich, industry expert and Vice President of Strategic Partnerships at YPrime will discuss how emerging IRT system functionality goes beyond management of patient randomization and drug supply.




SGD Holdings, Ltd. Executes Build to Suit Lease Agreement on Three Acres for the Construction of a Cannabis Processing and Extraction Facility

Thu, 20 Apr 2017 07:20:01 EDT

VENTURA, CA--(Marketwired - Apr 20, 2017) -  SGD Holdings, Ltd (OTC PINK: SGDH) has signed a Five Year Sub-Lease Agreement including multiple 3 year options for a three acre lot from CannaGrow Holdings, Inc. (OTC PINK: CGRW) on the same parcel as their Colorado Buffalo Ranch Grow Facility.




SPYRUS(R) Announces Hardware "Root of Trust" Product Family Supporting Microsoft Azure IoT Hub

Thu, 20 Apr 2017 03:01:00 EDT

SPYRUS FIPS 140-2 Level 3 Certified Devices Bring Strong Authentication to SAS Token and TLS/SSL Schema Azure IoT Hub




Cosmos Holdings, Inc. Announces Full-Year 2016 Results

Wed, 19 Apr 2017 17:58:23 EDT

Revenue Improved 1,166 Percent and Gross Profit Improved 1,126 Percent Year over Year




Cannabis Science Senior Executives Set to Present Drug Development Initiatives to Key Stakeholders Around the World at the Upcoming Global Health Catalyst Summit at Harvard Medical School Next Week, April 28 - 30th 2017

Wed, 19 Apr 2017 13:03:01 EDT

Cannabis Science Versus Cancer and Other Malignancies and the Palliative Care and Mental Health Sessions will be live-streamed to an audience worldwide




Parvus Therapeutics Announces Exclusive Worldwide License and Collaboration Agreement for the Development and Commercialization of Its Lead Nanomedicine to Treat Type 1 Diabetes

Wed, 19 Apr 2017 12:00:00 EDT

CALGARY, AB--(Marketwired - April 19, 2017) - Parvus Therapeutics, a biopharmaceutical company developing disease-modifying nanomedicines to halt or reverse autoimmune disease without causing general immune suppression, has entered into a license and collaboration agreement with Novartis for its lead Navacim for treating type 1 diabetes. Navacims constitute a novel pharmacological class of therapeutic comprised of nanoparticles (NPs) coated with disease-relevant peptide-major histocompatibility complexes (pMHCs) that alter the behavior of disease-causing T lymphocytes. Navacims are the first biopharmaceuticals to demonstrate in preclinical models the ability to restore immune tolerance in a disease-specific manner through in vivo formation and expansion of regulatory T-cells (T-regs) without causing general immune suppression.




ViaDerma, Inc. Announces its President, Dr. Christopher Otiko's Abstract was Well Received at the DFCON Conference as the Company Completes Final Testing for its FDA Registered Viabecline for Manufacturing in the Next Several Weeks

Wed, 19 Apr 2017 11:30:00 EDT

The Company is in the Final Phase of Testing its Proprietary Viabecline Formula for Manufacturing over the Next few Weeks and once Completed Will Start Manufacturing the Product for Distribution and Sales




Marijuana Company of America Announces Formation of Strategic Advisory Board

Wed, 19 Apr 2017 11:11:23 EDT

BONSALL, CA--(Marketwired - Apr 19, 2017) - Marijuana Company of America ("MCOA" or "the Company") (OTC PINK: MCOA), an innovative cannabis and marketing company, has established a Strategic Advisory Board, with the appointment of Noble DraKoln as Chairman, and the appointment of Andy Carter and David Hill as Advisors.




Desert Oasis Healthcare Establishes Center for Research and Healthcare Innovation Featuring Altura's HCP Studies(TM) Mobile Platform

Wed, 19 Apr 2017 08:30:00 EDT

Altura's Novel Study Engagement Platform(TM) to Help Create Optimized Clinical Study Ecosystem for Patients and Healthcare Providers




NetworkNewsWire Announces Publication Highlighting Advances in Cancer Therapy

Wed, 19 Apr 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Apr 19, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring TapImmune, Inc. (NASDAQ: TPIV), an NNW client focused on leading the field of oncology with its next-generation T-cell vaccines and novel immunotherapy platforms.




InfinityQS Launches Enact -- the Future of Manufacturing Quality

Wed, 19 Apr 2017 08:00:00 EDT

Enact Quality Intelligence platform redefines quality with unparalleled visibility and operational insight, creating a key gateway for manufacturing Industry 4.0 and the Industrial Internet of Things




Endexx Begins Shipment of Third Eye Chai CBD-Infused Gourmet Tea Beverages

Wed, 19 Apr 2017 08:00:00 EDT

Partnership with The Mad Hatter Coffee & Tea Co. to Tap into $47 Billion Global Tea Market




Lion Biotechnologies Announces Strategic Alliance with MD Anderson Cancer Center to Conduct Clinical Trials of TILs in Multiple Solid Tumors

Wed, 19 Apr 2017 08:00:00 EDT

SAN CARLOS, CA and HOUSTON, TX--(Marketwired - April 19, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology and The University of Texas MD Anderson Cancer Center, today announced a multi-year strategic alliance agreement involving multi-arm clinical trials to evaluate the safety and efficacy of TIL therapy in ovarian cancer, various sarcomas, and pancreatic cancer. In addition, preclinical research will explore the expansion of TIL in other rare tumor types.




Tetra Bio-Pharma & Aphria Announce Plans for the Joint Distribution of Dried Medical Cannabis in the Maritime Provinces & Quebec

Wed, 19 Apr 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - April 19, 2017) - Tetra Bio-Pharma Inc. ("Tetra") (CSE:TBP) (OTCQB:GRPOF) and Aphria Inc. ("Aphria") (TSX:APH) (OTCQB:APHQF), announced plans today for the joint distribution of dried medical cannabis in the maritime provinces and Quebec.




Technology Solutions for Late Phase Research: Optimizing Real World Data Assets, New Webinar Hosted by Xtalks

Wed, 19 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 19, 2017) - Michael Cook, Principal of Epidemiology and Bill Row, Divisional Principal of Real World Evidence both from ICON Commercialisation and Outcomes will outline how technological innovation can be applied to late phase research studies and how the smart application of that technology can enhance use of real world data (RWD) assets. The live event will take place on Monday, May 1, 2017 at 11am EDT (4pm BST/UK).




Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter

Wed, 19 Apr 2017 07:00:00 EDT

SALT LAKE CITY, UT--(Marketwired - Apr 19, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that it is delaying the filing of its Annual Report on Form 10-K for the year ended December 31, 2016 ("Form 10-K").




Dr. David Kuppersmith Joins The Steadman Clinic Staff

Wed, 19 Apr 2017 06:00:00 EDT

Internal Medicine Physician joins Clinic's lengthy list of world-renowned surgeons




Bradmer Announces Fourth Quarter and Full Year 2016 Financial Results

Tue, 18 Apr 2017 11:46:08 EDT

TORONTO, ONTARIO--(Marketwired - April 18, 2017) - Bradmer Pharmaceuticals Inc. (NEX:BMR.H) ("Bradmer" or the "Company") today announced its fourth quarter and full year 2016 financial results.




BioElectronics to Launch Educational Strategy: ActiPatch as the First Line of Defense Against Opioid Pain Medication

Tue, 18 Apr 2017 09:36:11 EDT

FREDERICK, MD--(Marketwired - Apr 18, 2017) - BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, over-the-counter pain management devices. The Company manufactures and markets its flagship product, ActiPatch® Chronic Musculoskeletal Pain Therapy as a drug-free, wearable nonprescription medical device that provides 720-hours of on/off therapy.




MyDx Announces Fiscal Year 2016 Results

Tue, 18 Apr 2017 09:20:00 EDT

SAN DIEGO, CA--(Marketwired - Apr 18, 2017) -  MyDx, Inc. (OTCQB: MYDX), a rapidly growing science and technology company that has developed MyDx®, the first multi-use handheld chemical analyzer for consumers, announces its 2016 fiscal year earnings results and management analysis. 




Proto Script Pharmaceutical Signs Medical Equipment Supply Agreement with PAKmed

Tue, 18 Apr 2017 09:03:05 EDT

RANCHO CUCAMONGA, CA--(Marketwired - Apr 18, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to announce that the Company has entered into a Supply Agreement with PAKmed LLC ("PAKmed"), a manufacturer of premium orthotic braces based in Louisville, Kentucky.




New EON AVR Platform Functionality Empowers Non-Technical Users To Inject Augmented Reality Knowledge Into Their World

Tue, 18 Apr 2017 09:00:00 EDT

New EON AVR Platform functionality allows instant creation of Augmented Reality annotations for physical objects and environments linked to location aware AR Knowledge Injections supported by Artificial Intelligence and IOT




Golden Arrow Makes a Big Jump from Junior to Producer -- SECFilings.com

Tue, 18 Apr 2017 09:00:00 EDT

REDONDO BEACH, CA--(Marketwired - Apr 18, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public filing alerts, recently published an article discussing Golden Arrow Resources' (TSX VENTURE: GRG) recent joint venture deal and the impact on the company as it makes the major transition to becoming a producer.




eWellness Plans the Launching of Multiple New Patient, Physician & PT Centric Platforms and Mobile Apps

Tue, 18 Apr 2017 09:00:00 EDT

CULVER CITY, CA--(Marketwired - Apr 18, 2017) - eWellness Healthcare Corporation - (OTCQB: EWLL), a provider of the state of the art PHZIO Platform for the physical therapy and telehealth markets, announced today that it plans to launch multiple new patient, physician and physical therapy (PT) centric platforms and mobile Apps over the next 8-10 weeks.




Medicine Man Technologies Files its 2016 Annual Report and Issues Revenue Guidance for Q1 2017

Tue, 18 Apr 2017 08:45:00 EDT

DENVER, CO--(Marketwired - Apr 18, 2017) - Medicine Man Technologies Inc. (OTCQB: MDCL), one of the country's leading cannabis branding and consulting companies, announced that the Company has filed its 2016 Annual Report on Form 10-K for the year ended December 31, 2016, and is providing guidance related to its first quarter 2017 performance.




Reading Health System Continues to Align and Engage Its Physician Leaders by Expanding the Reach of the Applied Physician Leadership Academy(C)

Tue, 18 Apr 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Apr 18, 2017) - Reading Health System, in conjunction with The Leadership Development Group, is changing its culture by focusing on physician leadership, alignment, and engagement. This month twenty-eight of the top ranked physician leaders from Reading Health System (RHS) graduated from The Leadership Development Group's Applied Physician Leadership Academy (APLA©), an 18-month customized leadership development program, designed to engage and develop physician leaders. And in January 2017, twenty-six emerging physician leaders joined together from across the organization to kick off a second cohort of the APLA that will run through March 2018. The program, intended to engage, inspire, and motivate leadership development for physicians, includes structured training courses focusing on development of leadership skills and competencies; mentoring and networking, assessments, coaching and feedback; and the process to apply learning and develop leadership competencies through work on real business problems.




Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer at Asana Medical, Inc.

Tue, 18 Apr 2017 08:00:00 EDT

MIAMI LAKES, FL--(Marketwired - Apr 18, 2017) - Asana Medical, Inc., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn's Disease, is pleased to announce that Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed as its Chief Business Officer.




Garlock to Exhibit at "Korea Pharm 2017"

Tue, 18 Apr 2017 08:00:00 EDT

PALMYRA, NY--(Marketwired - Apr 18, 2017) -




Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer

Tue, 18 Apr 2017 08:00:00 EDT

SAN CARLOS, CA--(Marketwired - April 18, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, highlighted today that a publication in the journal Science provided new translational data from a clinical trial of TIL therapy for the treatment of advanced metastatic cervical cancer conducted at the Surgery Branch of the National Cancer Institute (NCI). This trial has been supported in part by Lion under a Cooperative Research and Development Agreement (CRADA) with Dr. Steven Rosenberg, Chief of the Surgery Branch, National Cancer Institute (NCI), National Institutes of Health.




Si-Ware Systems Announces NeoSpectra Micro Development Kits

Tue, 18 Apr 2017 08:00:00 EDT

Development with NeoSpectra Micro Ushers in the Era of Universal Material Analysis




Aldeyra Therapeutics, Inc. Announces Last Patient Dosed in Allergic Conjunctivitis Phase 2b Clinical Trial

Tue, 18 Apr 2017 08:00:00 EDT

LEXINGTON, MA--(Marketwired - Apr 18, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes, today announced that the last patient has completed dosing in Aldeyra's multi-center, double-blind, randomized Phase 2b clinical trial of ADX-102 in allergic conjunctivitis. 




Stealth Mark Expands ActiveDuty's Power for Covert Ops

Tue, 18 Apr 2017 08:00:00 EDT

HOFFMAN ESTATES, IL--(Marketwired - Apr 18, 2017) - Wellness Center USA, Inc. (OTCQB: WCUI), today announced that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, is expanding its anti-counterfeiting ActiveDuty System to provide actionable intelligence in the worlds of money laundering and human trafficking/slavery. The scope of the work is being conducted in collaboration with prominent organizations, and is classified in nature.




Pharmaceutical Serialization for Late Starters -- With Live Industry Research Results from SEA Vision, New Webinar Hosted by Xtalks

Tue, 18 Apr 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - April 18, 2017) - In this live session, entitled 'pharmaceutical serialization for late starters', Carlos Machado, serialization director at SEA Vision US and Paolo Landriani, product manager at SEA Vision Italy will offer insight on how companies within the pharmaceutical industry can prepare for upcoming serialization regulations, with a view to guaranteeing long term success and compliance.




Nutritional High Announces Sale of FLI Cartridges to Nature's Herbs in Colorado

Tue, 18 Apr 2017 07:30:00 EDT

TORONTO, ONTARIO--(Marketwired - April 18, 2017) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(CSE:EAT.CN)(OTCQB:SPLIF)(FRANKFURT:2NU) is pleased to announce that Palo Verde LLC ("Palo Verde"), a company's licensed tenant in Colorado has filled a major order for Natures Herbs and Wellness Center in Colorado ("Natures Herbs").




60-Second Liver assessment: SuperSonic Imagine will demonstrate the performance of Real-Time ShearWave(TM) Elastography at the upcoming International Liver Congress (ILC 2017) in Amsterdam

Tue, 18 Apr 2017 06:00:00 EDT

AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 18, 2017) - SuperSonic Imagine (EURONEXT PARIS: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will showcase the clinical benefits of its real-time ShearWaveT Elastography (SWET) technology for non-invasive assessment of patients with chronic liver disease at the International Liver Congress (ILC 2017) or EASL, April 19 - 23 in Amsterdam.




CaliPharms Enters Acquisition Discussions with California Cannabis Retailers, Inc.

Mon, 17 Apr 2017 20:05:46 EDT

RIVERSIDE, CA--(Marketwired - Apr 17, 2017) - CaliPharms, Inc. (OTC PINK: KGET), a Company operating in the California Medicinal Cannabis industry, publicly trading under the OTC Markets symbol "KGET" is pleased to announce that CaliPharms has entered into acquisition discussions with United Cannabis Retailers, Inc. United Cannabis Retailers, Inc. is a cannabis product development company entering unfulfilled market niches in the cannabis sector. UCR is rolling out their first conceptual product line Canna-Kitchen this year. UCR is focused on promoting its brands.